Judith Inumerable is an accomplished Senior Director and Clinical Research Scientist at Cullinan Oncology, leading pivotal research programs in hematology. With prior experience as Director of Clinical Research at Genmab and significant roles at Bristol Myers Squibb, Celgene, Daiichi Sankyo, Novartis, Merck, and Johnson & Johnson, Judith has focused on various oncology programs, including Phase 3 clinical trials and bispecific T cell engagers. Educational credentials include an MBEE in Biotechnology from The Johns Hopkins University, a Masters and PGCert in Biotechnology Management from Harvard University, and an MBA Certificate in Pharmaceutical Science from Fairleigh Dickinson University-Florham Campus.